Helicobacter Pylori: a comprehensive review for primary care providers

1. PINCOCK S. Nobel Prize winners Robin Warren and Barry Marshall. Lancet. 2005; 366(9495):1429.10.1016/S0140-6736(05)67587-3Search in Google Scholar

2. HOOI JKY., LAI WY., Ng WK., SUEN MMY., UNDERWOOD FE., TANYINGOH D., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153(2):420–9.10.1053/j.gastro.2017.04.02228456631Search in Google Scholar

3. PARKINSON AJ., GOLD BD., BULKOW L., WAINWRIGHT RB., SWAMINATHAN B., KHANNA B., et al. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000; 7(6):885–8.10.1128/CDLI.7.6.885-888.20009597911063492Search in Google Scholar

4. EVERHART JE., KRUSZON-MORAN D., PEREZ-PEREZ GI., TRALKA TS., MCQUILAN G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000; 181(4):1359–63.10.1086/31538410762567Search in Google Scholar

5. CARDENAL VM., MULLA ZD., ORTIZ M., GRAHAM DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006; 163(2):127–34.10.1093/aje/kwj01816306309Search in Google Scholar

6. SCHWARZ S., MORELLI G., KUSECEK B., MANICA A., BALLOUX F., OWEN RJ., et al. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008; 4(10):e1000180.10.1371/journal.ppat.1000180256368618949030Search in Google Scholar

7. FORD AC., FORMAN D., BAILEY AG., GOODMAN KJ., AXON AT., MOAYYEDI P. Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study. Int J Epidemiol. 2007; 36(6):1327–33.10.1093/ije/dym20117905807Search in Google Scholar

8. WEYERMANN M., ROTHENBACHER D., BRENNER H. Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol. 2009; 104(1):182–9.10.1038/ajg.2008.6119098867Search in Google Scholar

9. JIANG J., CHEN Y., SHI J., SONG C., ZHANG J., WANG K. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017; 36(2):199–212.10.1007/s10096-016-2810-x27771779Search in Google Scholar

10. GONI E., FRANCESCHI F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016; 21 Suppl 1:45–8.10.1111/hel.1234027531539Search in Google Scholar

11. LIU J., WANG F., SHI S. Helicobacter pylori Infection Increase the Risk of Myocardial Infarction: A Meta-Analysis of 26 Studies Involving more than 20,000 Participants. Helicobacter. 2015; 20(3):176–83.10.1111/hel.12188Search in Google Scholar

12. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994; 61:1–241.Search in Google Scholar

13. KOSUNEN TU., PUKKALA E., SARNA S., SEPPALA K., AROMAA A., KNEKT P., et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study. Int J Cancer. 2011; 128(2):433–9.10.1002/ijc.25337Search in Google Scholar

14. CHEY WD., LEONITIADIS GI., HOWDEN CW., MOSS SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017; 112(2):212–39.10.1038/ajg.2016.563Search in Google Scholar

15. NAKAMURA S., SUGIYAMA T., MATSUMOTO T., IIJIMA K., ONO S., TAJIKA M., et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012; 61(4):507–13.10.1136/gutjnl-2011-300495Search in Google Scholar

16. YOON SB., PARK JM., LIM CH., CHO YK., CHOI MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014; 19(4):243–8.10.1111/hel.12146Search in Google Scholar

17. RAGHUNATH AS., HUNGIN AP., WOOFF D., CHILDS S. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther. 2004; 20(7):733–44.10.1111/j.1365-2036.2004.02172.xSearch in Google Scholar

18. HOWDEN CW., HUNT RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998; 93(12):2330–8.Search in Google Scholar

19. GRAHAM DY., MIFTAHUSSURUR M. Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: A mini review. J Adv Res. 2018; 13:51–7.10.1016/j.jare.2018.01.006Search in Google Scholar

20. CHEY WD., WONG BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102(8):1808–25.10.1111/j.1572-0241.2007.01393.xSearch in Google Scholar

21. TREVISANI L., SARTORI S., GALVANI F., ROSSI MR., RUINA M., CHIAMENTI C., et al. Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study. Am J Gastroenterol. 1999; 94(7):1830–3.10.1111/j.1572-0241.1999.01213.xSearch in Google Scholar

22. VAIRA D., MALFERHEINER P., MEGRAUD F., AXON AT., DELTENRE M., HIRSCHL AM., et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet. 1999; 354(9172):30–3.10.1016/S0140-6736(98)08103-3Search in Google Scholar

23. MALFERHEINER P., MEGRAUD F., O’MORAIN CA., ATHERTON J., AXON AT., BAZZOLI F., et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut. 2012; 61(5):646–64.10.1136/gutjnl-2012-302084Search in Google Scholar

24. MALFERHEINER P., MEGRAUD F., MORAIN CA., GISBERT JP., KUIPERS EJ., AXON AT., et al. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut. 2017; 66(1):6.10.1136/gutjnl-2016-312288Search in Google Scholar

25. YANEZ P., LA GARZA AM., PEREZ-PEREZ G., CABRERA L., MUNOZ O., TORRES J. Comparison of invasive and noninvasive methods for the diagnosis and evaluation of eradication of Helicobacter pylori infection in children. Arch Med Res. 2000; 31(4):415–21.10.1016/S0188-4409(00)00087-4Search in Google Scholar

26. BRANDI G., BIAVATI B., CALABRESE C., GRANATA M., NANNETTI A., MATTARELLI P., et al. Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol. 2006; 101(8):1756–61.10.1111/j.1572-0241.2006.00698.x16780553Search in Google Scholar

27. WRIGHT CL., KELLY JK. The use of routine special stains for upper gastrointestinal biopsies. Am J Surg Pathol. 2006; 30(3):357–61.10.1097/01.pas.0000184808.45661.cb16538056Search in Google Scholar

28. GENTA RM., GRAHAM DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994; 40(3):342–5.Search in Google Scholar

29. TAYLOR DE., GE Z., PURYCH D., LO T., HIRATSUKA K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother. 1997; 41(12):2621–8.10.1128/AAC.41.12.26211641809420030Search in Google Scholar

30. HIRSCHL AM., MAKRISTATHIS A. Methods to detect Helicobacter pylori: from culture to molecular biology. Helicobacter. 2007; 12 Suppl 2:6–11.10.1111/j.1523-5378.2007.00560.x17991170Search in Google Scholar

31. YUAN Y., FORD AC., KHAN KJ., GISBERT JP., FORMAN D., LEONTIADIS GI., et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013; (12):Cd008337.10.1002/14651858.CD008337.pub224338763Search in Google Scholar

32. FALLONE CA., CHIBA N., VAN ZANTEN SV., FISCHBACH L., GISBERT JP., HUNT RH., et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016; 151(1):51–69.e14.10.1053/j.gastro.2016.04.00627102658Search in Google Scholar

33. LI BZ., THREAPLETON DE., WANG JY., XU JM., YUAN JQ., ZHANG C., et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. Bmj. 2015; 351:h4052.10.1136/bmj.h4052454116826290044Search in Google Scholar

34. NISTA EC., CANDELLI M., CREMONINI F., CAZZATO IA., DI CAROA S., GABRIELLI M., et al. Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther. 2003; 18(6):627–33.10.1046/j.1365-2036.2003.01676.xSearch in Google Scholar

35. BILARDI C., DULBECCO P., ZENTILIN P., REGLIONI S., IIRITANO E., PARODI A., et al. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol. 2004; 2(11):997–1002.10.1016/S1542-3565(04)00458-6Search in Google Scholar

36. SAAD RJ., SCHOENFELD P., KIM HM., CHEY WD. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol. 2006; 101(3):488–96.10.1111/j.1572-0241.2006.00637.xSearch in Google Scholar

37. ERCIN CN., UYGUN A., TOROS AB., KANTARCIOGLU M., KILCILER G., POLAT Z., et al. Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia. Turk J Gastroenterol. 2010; 21(1):12–6.10.4318/tjg.2010.0041Search in Google Scholar

38. BASU PP., RAYAPUDI K., PACANA T., SHAH NJ., KRISHNASWAMY N., FLYNN M. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am J Gastroenterol. 2011; 106(11):1970–5.10.1038/ajg.2011.306Search in Google Scholar

39. KALE-PRADHAN PB., MIHAESCU A., WILHELM SM. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis. Pharmacotherapy. 2015; 35(8):719–30.10.1002/phar.1614Search in Google Scholar

40. GREENBERG ER., ANDERSON GL., MORGAN DR., TORRES J., CHEY WD., BRAVO LE., et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011; 378(9790):507–14.10.1016/S0140-6736(11)60825-8Search in Google Scholar

41. MIEHLKE S., HHANSKY K., SCHNEIDER-BRACHERT W., KIRSCH C., MORGANER A., MADISCH A., et al. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment Pharmacol Ther. 2006; 24(2):395–403.10.1111/j.1365-2036.2006.02993.x16842467Search in Google Scholar

42. LABENZ J. Current role of acid suppressants in Helicobacter pylori eradication therapy. Best Pract Res Clin Gastroenterol. 2001; 15(3):413–31.10.1053/bega.2001.018811403536Search in Google Scholar

43. SHIOTA S., REDDY R., ALSARRAJ A., EL-SSERAG HB., GRAHAM DY. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015; 13(9):1616–24.10.1016/j.cgh.2015.02.005690508325681693Search in Google Scholar

44. PERRI F., FESTA V., CLEMENTE R., VILLANI MR., QUITADAMO M., CARUSO N., et al. Randomized study of two “rescue” therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol. 2001; 96(1):58–62.Search in Google Scholar

45. GISBERT JP., ABRAIRA V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006; 101(4):848–63.10.1111/j.1572-0241.2006.00528.x16494583Search in Google Scholar

46. GISBERT JP., ESTEBAN C., JIMENEZ I., MORENO-OTERO R. 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Helicobacter. 2007; 12(3):231–7.10.1111/j.1523-5378.2007.00492.x17493003Search in Google Scholar

47. MIEHLKE S., KIRSCH C., SCHNEIDER-BRACHERT W., HHAFERLAND C., NEUMEYER M., BASTLEIN E., et al. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter. 2003; 8(4):310–9.10.1046/j.1523-5378.2003.00158.x12950604Search in Google Scholar

48. CAO Z., CCHEN Q., ZHANG W., LIANG X., LIAO J., LIU W., et al. Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial. Scand J Gastroenterol. 2015; 50(10):1185–90.10.3109/00365521.2015.103734525881966Search in Google Scholar

49. DONG SQ., SINGH TP., WEI X., YAO H., WANG HL. Review: A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion? Helicobacter. 2017; 22(6):e12438.10.1111/hel.1243828884937Search in Google Scholar